Organization
Besançon University Hospital
2 abstracts
Abstract
Prognosis factors for long-term eribulin response in a cohort of patients with HER2-negative metastatic breast cancer.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, CHU Besançon, Besançon, Department of medical onclogy, Peking Union Medical College Hospital, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
ASSOCIATION OF CANCER AND ANTISYNTHETASE SYNDROME: A RETROSPECTIVE MULTICENTER STUDYOrg: Nancy University Hospital, Dijon University Hospital, University of Bourgogne-Franche Comté, Lorraine University, Paris Descartes University, EA 4360 Apemac, Nancy, Bourgogne-Franche Comté University,